Is the halt related to the following on Page 2
https://botanixpharma.com/wp-content/uploads/BOT.ASX-BOT-Successful-FDA-MidCycle-Review-040623.pdf
BOT had $8.7m in cash as of the december quarter. BOT is not due to make the nextUS$4m milestone payment to Fresh Tracks Therapeutics (previously Brickell Biotech) untilthe receipt of FDA approval (if received before 30th September, less due if thereafter).
Other milestone payments due to Fresh Tracks are tied to net sales, and won’t begin untilnet sales exceed US$75m per annum.
- Forums
- ASX - By Stock
- BOT
- Ann: Trading Halt
Ann: Trading Halt, page-66
-
-
- There are more pages in this discussion • 143 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
35.5¢ |
Change
0.010(2.90%) |
Mkt cap ! $642.5M |
Open | High | Low | Value | Volume |
34.0¢ | 36.0¢ | 34.0¢ | $1.005M | 2.886M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 75000 | 35.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.0¢ | 312537 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 75000 | 0.355 |
4 | 104000 | 0.350 |
1 | 100000 | 0.345 |
10 | 246843 | 0.340 |
3 | 131000 | 0.335 |
Price($) | Vol. | No. |
---|---|---|
0.360 | 312537 | 10 |
0.365 | 103407 | 4 |
0.370 | 153400 | 5 |
0.375 | 62000 | 2 |
0.380 | 300498 | 9 |
Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online